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Abstract
Previous animal models of acute lung injury (ALI) are limited as they only reproduce part of the
complex pathobiology of clinical ALI. Here we develop a translational mouse model of ALI,
which not only reflects the major clinical and pathological features but also enables investigation
into ALI resolution.
Anaesthetised mice underwent orotracheal instillation of hydrochloric acid. During the immediate
period after instillation, mice were carefully maintained with supplemental oxygen to avoid
mortality. At specified time points, lung injury was assessed by blood gases, respiratory
mechanics, analysis of bronchoalveolar lavage fluid, alveolar fluid clearance and lung histology.
Animals exhibited significant weight loss, decreased oxygenation, increased respiratory elastance,
and pulmonary inflammation (intra-alveolar leucocyte influx/ cytokine levels and histological
injury scores). Moreover, mice displayed alveolar-capillary barrier dysfunction/epithelial injury as
reflected by increased alveolar protein, lung wet/dry weight ratio and soluble Receptor for
Advanced Glycation End-products, as well as reduced alveolar fluid clearance. These injury
parameters peaked between days 1-3, followed by almost complete recovery over days 5-10.
Histology showed evidence of fibrosis at day 10.
The results indicate that this resolving model of acid aspiration represents a powerful experimental
tool to investigate the injurious, inflammatory, fibrotic, and resolving and reparative processes of
ALI.
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INTRODUCTION
Acute lung injury (ALI), or its more severe form acute respiratory distress syndrome
(ARDS), continues to cause significant morbidity and mortality (1). It is characterised by an
acute exudative phase involving pulmonary oedema and inflammation, which lead to severe
hypoxaemia often necessitating mechanical ventilation. Recovery from ALI involves phases
of resolution and repair, which may include substantial lung fibrosis. However, the
mechanisms that govern whether and how these pathophysiological processes occur remain
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poorly understood (2). One of the primary reasons for this lack of understanding is the
nature of existing pre-clinical models, insofar as none fully replicate the complex
pathobiology of clinical ALI. The majority of animal studies have focused on mechanisms
within the acute exudative phase, and very few models allow examination of the later phases
of inflammation, resolution and repair. These issues have been particularly highlighted in a
recent American Thoracic Society Workshop report on the features required to model
experimental ALI in animals (3), as well as by other reviews highlighting the need for true
translational modelling of ALI/ARDS (4, 5).
The acid aspiration paradigm has been described as potentially the most translatable model
of direct ALI/ARDS, because there is a clear clinical correlate (5). Despite this, only 3% of
recent literature has utilised acid aspiration (4). This is most likely due to a narrow dosing
window between no injury and overwhelming injury leading to high mortality. To
circumvent this issue, most models utilising acid aspiration either include mechanical
ventilation to maintain animals, which limits investigators to the acute phases (< 4-6 hours)
of ALI/ARDS (6, 7), or use lower acid volume, higher pH acid and/or unilateral pulmonary
instillation to improve survival (8, 9). However, these latter approaches arguably may not
reproduce the severity (not to mention bilateral nature) of clinical ALI that is required to be
truly translational.
In this study, we have developed, optimised and characterised a model of acid aspiration that
reproduces many of the physiological, biological and pathological changes found in human
ALI/ARDS, and moreover shows virtually full resolution by 5-10 days. We believe that this
model will be of substantial use to further our understanding of human ALI/ARDS, in
particular those processes regulating resolution and repair.
METHODS
Animal model of acid aspiration
All protocols were approved by the Ethical Review Board of Imperial College London, and
carried out under the authority of the UK Home Office in accordance with the Animals
(Scientific Procedures) Act 1986, UK. We used male C57BL6 mice (Charles River,
Margate, UK) aged 10–12 weeks and weighing 25-30g. In total 68 animals were used – 23
for measurements of respiratory mechanics and alveolar inflammation, 25 for assessing
alveolar fluid clearance, and 20 for lung wet/dry weight and histology scoring.
Mice were anaesthetised by intraperitoneal injection of xylazine (6mg/kg) and ketamine
(60mg/kg), and given an intraperitoneal fluid bolus of 10μl/g 0.9% normal saline as
preemptive fluid resuscitation. Mice were suspended vertically from their incisors on a
custom-made mount for orotracheal instillation, as described previously (10) (additional
details are provided in the online supplement). A fine catheter was guided 1cm below the
vocal cords, and 75μl of an isoosmolar (to mouse plasma - 322mosmol/L) solution of 0.1M
hydrochloric acid (pH 1.0) was instilled. For the next 4 hours, during which animals
exhibited significant respiratory depression/distress as an acute result of acid aspiration-
induced ALI, mice were kept in a custom-made transparent recovery box under humidified
supplemental oxygen (FiO2 reduced gradually from 1.0 to 0.21). During this period animals
were carefully monitored and body temperature was maintained using external heat sources,
after which they were transferred to individually ventilated cages with air and free access to
food and water.
Physiological Measurements
At specified time-points (1, 2, 3, 5 and 10 days) after acid instillation, animals were weighed
and underwent surgical preparation for mechanical ventilation, to conduct standardised
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assessment of pulmonary gas exchange capability and respiratory mechanics. The
preparation for mouse mechanical ventilation and pulmonary function tests has been
described in detail previously (11, 12). In brief, mice were anaesthetised, tracheostomised
and ventilated using a custom-made ventilator, with the left carotid artery cannulated for
monitoring arterial blood gases and blood pressure. After an initial lung recruitment
manoeuvre (30cmH2O, 5sec), animals were ventilated for 30 min (tidal volume 8-9 ml/kg,
positive end-expiratory pressure 2.5cmH2O, respiratory rate 120 breaths/minute, FiO2 1.0)
to standardise the volume history of the lungs. At the end of ventilation, blood gases were
measured and respiratory mechanics determined using the end-inspiratory occlusion
technique, as described previously (11, 13). Acid-injured animals were compared to
otherwise untreated mice, receiving just the surgical preparation and 30 minute ventilation
procedures.
Pulmonary inflammation
At the end of the above procedure, mice were sacrificed by anaesthetic overdose.
Bronchoalveolar lavage (BAL) was performed with 750μl of saline as described previously
(11) and the samples were centrifuged at 240 x g. Protein levels in BAL fluid (BALF) were
quantified (Bio-Rad Laboratories, Hemel Hempstead, UK) and BALF levels of IL-6, TNF-
α, keratinocyte-derived chemokine (KC), macrophage inflammatory protein-2 (MIP-2), and
soluble Receptor for Advanced Glycation End-products (RAGE) were determined using
ELISA assay kits (R&D Systems, Abingdon, UK). BALF cell counts were obtained by
haemocytometer, with differential cytology performed on Diff-Quik-stained samples
prepared by cytospin (Shandon, Runcorn, UK).
Alveolar Fluid Clearance
In a separate series of experiments, alveolar fluid clearance (AFC) was determined at days 1,
2, 3, 5 and 10 after acid instillation (and in untreated animals), using a modification of
previously described in situ models (14). Mice were anaesthetised, tracheostomised,
cannulated via the carotid artery, and ventilated as described above. After intravenous
heparinisation (20 units), animals were sacrificed and exsanguinated to drain pulmonary
vessels and minimise any potential impact of pulmonary vascular pressure on AFC. Each
animal then received 3 lung recruitment manoeuvres, to standardise volume history of the
lungs and further empty compliant vessels. The entire procedure took no more than 15
minutes.
Mice then underwent intratracheal instillation with 700μl of an isoosmolar medium
containing 5% low endotoxin bovine serum albumin (BSA, Sigma-Aldrich Ltd, Dorset, UK)
and 50μg/ml fluorescent AlexaFluor 594-conjugated BSA (Invitrogen, Paisley, UK).
Without disconnecting the instillation syringe, 400μl of instillate was immediately
withdrawn and re-instilled, followed by removal of a first aliquot of 200μl as a t=0 reference
sample. This process ensured homogeneous distribution of the instillate, and that the
reference sample was as representative of alveolar contents as possible. Mice were placed on
a continuous positive airway pressure system delivering 100% oxygen at 8cmH2O, and
maintained at a temperature of 36.5-38°C throughout. Thirty minutes after instillation, a
surgical pneumothorax was induced to maximise recovery of the remaining instillate from
the lungs. Percentage AFC over 30 minutes was determined by the equation: [1-(F0/F30)]
×100, where F0 is the fluorescence of the t=0 reference sample and F30 is the fluorescence
of the t=30 sample. More detailed methodology can be found in the online supplement.
Lung injury scoring
In a separate series of experiments, acid injured mice (at each time point) and untreated
animals were sacrificed and their left lungs instilled and inflated at 15cmH2O with 4%
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paraformaldehyde and removed for paraffin embedding. Slices at 10μm thickness were
subsequently stained with haematoxylin and eosin (Sigma-Aldrich Ltd, Dorset, UK), or
Masson’s Trichrome stain (Sigma-Aldrich Ltd, Dorset, UK) for fibrosis. Lung injury scores
were quantified by an investigator blinded to the treatment groups using recently published
criteria, which gives an overall score of between 0 and 1 (3) (see online supplement for
details). The right lungs were tied off prior to paraformaldehyde instillation, and removed
for determination of lung wet/dry weight ratio.
Statistics
Data are expressed as means±SD. Statistical analyses of physiological parameters were
carried out by one-way ANOVA with Bonferroni tests for pairwise comparisons between
each time-point and uninjured controls (represented as Day 0). We used Spearman’s
correlation coefficients to test the correlations between RAGE levels and other continuous
variables. Statistical significance was defined as p<0.05.
RESULTS
Physiology
Mice showed significant weight loss in the first 3 days after acid instillation despite initial
fluid resuscitation, which subsequently returned to pre-injury levels by day 10 (figure 1a).
During the first two days, animals showed reduced movement, piloerection and laboured
breathing suggesting injury. Consistent with this, compared to uninjured animals (day 0),
arterial oxygenation significantly deteriorated by day 1 after injury with gradual
improvement by day 5 (figure 1b). Mean PaO2:FiO2 ratios achieved clinical ARDS criteria
(<200) on day 1 and ALI criteria (<300) on days 2 and 3. Respiratory system elastance
substantially increased at days 1 and 2 after injury, and then returned toward baseline from
day 3 (figure 1c). There were no significant changes in respiratory system resistance (data
not shown). Additionally, wet/dry weight ratio was determined to assess lung water content,
and this showed a significant 61% increase at day 1, which declined towards normal limits
by day 3 (figure 1d).
Alveolar inflammation
BAL cytology showed a dramatic change in cellularity within the alveolar space following
injury (figure 2a and b). Before instillation the cellular content was virtually exclusively
alveolar macrophages. Following acid instillation the proportion of neutrophils increased
dramatically, with BAL neutrophil numbers showing a peak on day 2 followed by a
significant drop by day 3 and effective absence by day 10. In addition, we found a gradual
increase in lymphocyte proportion following aspiration, and by day 10 (once neutrophils had
disappeared) they constituted up to 15% of the total cell population (see online supplement).
The temporal profile of neutrophil alveolitis was mirrored by changes in BALF levels of
mouse neutrophil chemokines MIP-2 and KC (figure 2c and d) and the pro-inflammatory
mediators IL-6 and TNF (figure 2e and f).
Alveolar epithelial dysfunction
Alveolar-capillary barrier permeability as assessed by BALF protein showed a substantial
increase at day 1 with return to normal levels by day 10 (figure 3a). BALF levels of RAGE
were also significantly upregulated at day 1, which subsequently reduced and were near
baseline by day 3 (figure 3b). BALF soluble RAGE levels were found to inversely correlate
with PaO2:FiO2 (r=−0.71, p < 0.01 – figure 3c). Finally, we examined alveolar epithelial
function through measurement of AFC rate (figure 3d), which showed a significant
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deterioration during the first two days after acid instillation. Interestingly, the lungs regained
the ability to clear fluid after day 3, suggesting a restoration of alveolar epithelial function.
Lung injury scoring
Acid aspiration caused substantial changes in lung architecture compared to uninjured
controls. Over the first 48 hours there were disrupted alveoli and the presence of fluid and
haemorrhage within the alveolar space (figure 4a-c). The alveolar walls were markedly
thickened with the presence of a neutrophilic and mononuclear infiltrate, and there was
hyaline membrane deposition. After day 3 lung neutrophil infiltration, alveolar structure and
debris were somewhat normalised, but there remained a cellular infiltrate, predominantly
mononuclear in nature (figure 4d-f). Overall, lung injury scores were significantly increased
on days 1 and 2 (figure 4g). In addition, bronchiolar walls were thickened suggesting
collagen deposition. Confirming this possibility, sections stained with Masson’s Trichrome
showed increased collagen throughout, particularly in the walls of proximal to terminal
bronchioles (figure 5).
DISCUSSION
Although multiple potential molecular targets have been identified and shown to be effective
in animal models of ALI, none have yet translated to clinical benefit for patients with ALI/
ARDS. One of the major pitfalls to translation between bench and bedside is the diversity of
animal models that do not fully reproduce the human condition. Indeed, recent reviews have
highlighted the features required to optimally model ALI/ARDS, and that no current animal
model replicates the complexities of this devastating disorder (3, 4, 15). In this study, we
describe a mouse model of ALI/ARDS induced by bilateral instillation of acid, which we
believe represents a significant step forward in terms of reproducing the vast majority of the
main pathophysiological hallmarks of clinical ALI/ARDS.
The primary goal of the current study was to develop a model which induced substantial
injury, but had low mortality over time allowing investigation into the resolution/repair
processes from this highly injured baseline. Existing models are rarely able to capture both
of these aspects. Experimental paradigms such as high stretch mechanical ventilation (16),
intravenous oleic acid (17) and sepsis induced by caecal ligation and puncture (18) can
induce overwhelming injury over a timescale from hours to days, but do not then allow
investigation into repair/resolution. On the other hand, models such as intratracheal
endotoxin and bleomycin may allow investigation of certain aspects surrounding resolution
of inflammation and fibrotic processes that can occur following clinical ALI/ARDS, but do
not produce the substantial hypoxaemia that is a prerequisite for disease diagnosis (4).
Bilateral instillation of acid of similar concentrations to that used in this study has been
reported to produce significant early mortality in mice (9). This is most likely due to
substantial bronchospasm and upper airway oedema caused by acid administration, and/or
severe hypoxaemia during the acute phase of lung injury combined with respiratory
depression produced by anaesthesia. Whereas other studies have circumvented this by
reducing the dose/strength of acid (8, 9) or utilising mechanical ventilation (6), we found
that careful airway manipulation during instillation, as well as the use of supplemental
oxygen with maintenance of humidity/temperature over the initial hours after instillation
successfully reduced mortality to zero. Acid instillation did however lead to a significant
weight loss which lasted for the first 3 days of injury, despite the initial fluid bolus given.
We previously found using exactly the same anaesthetic regimen and instillation technique,
that low dose endotoxin instillation leads to a weight loss of only ~2% at 24 hours (10), as
compared to ~8% currently. Thus, the degree of weight loss in the current model likely truly
reflects disease severity and progression.
Patel et al. Page 5
Eur Respir J. Author manuscript; available in PMC 2013 February 09.
Due to their compliant rib cage, anaesthesia and surgical preparation in mice inevitably
induces some alveolar collapse until mechanical ventilation is established. The degree of
such lung collapse and its effects on respiratory physiology parameters are often difficult to
control. We therefore assessed arterial blood gases and respiratory mechanics in these acid-
injured animals (and untreated controls) after the rigorous standardisation of volume history
of their lungs, i.e. a recruitment manoeuvre followed by a short period of positive pressure
ventilation with 100% O2. During the first 3 days after aspiration, both respiratory system
mechanics and arterial oxygenation were substantially deteriorated compared to normal.
Indeed, oxygenation reached the criteria for clinical ALI/ARDS over the first 3 days,
making the zero mortality and effectively full recovery by days 5-10 all the more
remarkable. This lack of mortality during the peak of injury (days 1-2) may also be specific
to the acid model with minimal haemodynamic compromise, as compared to other ALI
models such as high dose lipopolysaccharide, caecal ligation puncture, and oleic acid.
Previous studies have demonstrated the importance of pulmonary inflammation within ALI.
Animal studies have identified multiple inflammatory mediators that, when interfered with,
attenuate injury (19), while clinical studies have shown strong correlations between various
mediators and mortality (20). Successful recovery from ALI therefore requires adequate and
timely resolution of inflammation (21). Although the majority of preclinical trials target
inflammatory pathways prophylactically or very soon after injury induction, in reality most
ALI patients present at a much later point in the progression of disease, implying that a more
realistic target may be the enhancement of inflammatory resolution. The removal of
neutrophils from the alveolar space is an absolute necessity for resolution to occur (22). In
the current model we found a peak of BAL neutrophil numbers at day 2 that dramatically
declined by day 3. The continued increase in neutrophils (and TNF levels) in the alveolar
space up to 48 hours is consistent with a previous study of acid aspiration (23), although that
study did not investigate later time points. The presence of neutrophils in the alveolar space
and the interstitium are the major determinants of the lung injury score utilised in this study
(see online supplement), and the reduced injury score from day 3 confirmed that neutrophils
are removed not only from the alveoli but also the lung itself, rather than migrating/
redistributing elsewhere within the lung compartments that is not accessible by BAL.
Although the fate of neutrophils has not been specifically investigated, it is most likely that
they undergo apoptosis followed by efferocytosis by alveolar macrophages (24, 25), which
is crucial for resolution of the inflammatory response. The reduction in neutrophil levels was
effectively mirrored by changes in soluble proinflammatory mediators, also consistent with
a significant shift in the alveolar milieu from a proinflammatory state to a proresolution state
between days 2-3. Finally, an increase in the proportion of lymphocytes within the alveolar
space was apparent towards day 10 after injury, which may be consistent with recent work
highlighting the potential involvement of regulatory T-cells in ALI resolution (26).
It has been shown that alveolar oedema formation in ALI/ARDS is associated with epithelial
dysfunction (27). The deterioration in respiratory mechanics observed reflects a combination
of pulmonary oedema and alveolar collapse, and increased BALF protein levels and lung
wet/dry weight ratio confirm significant alveolar permeability and oedema during the acute
phase of injury in this model. A variety of specific biomarkers for epithelial injury during
ALI have been proposed, with RAGE the most recently advocated (28). RAGE is expressed
on the basal surface of type 1 epithelial cells, and has been shown to increase in BALF and
plasma of patients with ALI/ARDS (29). In murine models of acid aspiration, BALF RAGE
level was also found to correlate strongly with pH of acid instilled (30). We found that
BALF soluble RAGE levels correlate with oxygenation, which suggests that our model
produces significant epithelial dysfunction and its subsequent resolution. In addition to
worsening barrier permeability, we found that acid instillation led to reduced alveolar fluid
clearance. Acid aspiration models have been shown to reduce AFC (31), but we show for the
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first time in this model an improvement in AFC after day 2, strongly suggestive of epithelial
resolution and repair. This improvement coincides with the resolution of many other
parameters on day 3.
It is uncertain why ALI/ARDS resolution involves fibrosis in some patients but not others.
Very few animal models allow investigation of this reparative process, particularly from a
starting point of substantial initial injury. Evidence of increased collagen deposition from
proximal to distal bronchioles was found within 48 hours after acid, progressing to
substantially increased numbers of fibrotic foci by day 10. It is possible that this fibrosis
may explain why lung elastance did not completely revert to normal values at day 10,
maintaining a 16% increase compared to uninjured controls. Despite the generalised alveolar
disruption observed on day 2, there was some return to recognisable alveolar architecture by
day 10 and a reduction in alveolar debris. Although interstitial cellularity was still present at
day 10, this mainly consisted of mononuclear cells and lymphocytes. Investigation of the
relevance of such cell types (including monocyte and macrophage subsets) will be a major
goal for further study utilising this model.
In conclusion, the acute injurious phase of the acid aspiration model has been well
characterised and has been described as the most clinically applicable model available (32).
While previous studies utilising this model have frequently reduced (in our opinion) its
translatability by using unilateral instillation or small doses of acid to limit injury, by careful
airway management and recovery we were able to develop a model which replicates major
hallmarks of human ALI/ARDS - acute onset, bilateral injury leading to severe hypoxaemia
with increased respiratory elastance, impaired alveolar fluid clearance, epithelial damage
and barrier permeability, with repair involving fibrosis. While the degree of injury is
difficult to compare to the human situation, the level of hypoxaemia is similar to that
observed during clinical ALI/ARDS, and other parameters determined (BALF protein, lung
wet/dry weight ratio) are of similar or greater magnitude to other models of ‘substantial/
lethal’ ALI (e.g. caecal ligation and puncture (33), oleic acid (34) and ventilator-induced
lung injury (12)). We believe that this animal model provides a powerful translational
platform to truly model clinically relevant situations by recapitulating human ALI/ARDS in
terms of disease profile, severity and time course. Such a model should allow us to better
investigate the pathological processes, the effects of clinically applicable secondary insults,
and potential therapeutic interventions, particularly those focusing on resolution and repair.
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Figure 1.
a) Body weight changes as represented by percentage of original body mass (N=9-11/each
time point). b) Arterial oxygenation as measured by PaO2:FiO2 at different stages of lung
injury (N=5-7/each time point). c) Respiratory system elastance (N=3-5/each time point) and
d) lung wet/dry weight ratio (N=3-4/each time point) at different time points after acid
instillation. ***P<0.001, ** P<0.01, *P<0.05 vs Day 0 uninjured controls.
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Figure 2.
BAL a) numbers and b) proportions of polymorphonuclear neutrophils, mononuclear cells,
and lymphocytes within the model (N=3-5/each time point).Measurement of BAL fluid
(BALF) levels of chemokines c) macrophage inflammatory protein (MIP)-2 and d)
keratinocyte-derived chemokine (KC). BALF cytokines e) tumour necrosis factor (TNF)-
alpha and f) interleukin (IL)-6 after acid aspiration (N=3-6/each time point). ***P<0.001, **
P<0.01, *P<0.05 vs Day 0 uninjured controls.
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Figure 3.
a) Changes in alveolar-capillary barrier permeability as measured by BALF protein level
(N=3-6/each time point). b) Measurement of BALF soluble RAGE levels as a marker of
type 1 alveolar epithelial injury (N=3-6/each time point). c) PaO2:FiO2 plotted against log
transformed RAGE shows that oxygenation inversely correlated with the level of alveolar
RAGE (R=−0.71, P<0.01). Each data point represents a separate animal. d) Measurement of
alveolar fluid clearance rate as a marker of epithelial function (N=3-6/each time point).
***P<0.001, ** P<0.01, * P<0.05 vs Day 0 uninjured controls.
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Figure 4.
a–f) Representative haematoxylin and eosin (H&E)-stained sections at 6400 original
magnification of uninjured and injured animals at all time-points after acid aspiration. a)
Day 0, b) day 1, c) day 2, d) day 3, e) day 5 and f) day 10. There is greater cellularity
consisting mainly of neutrophils (white arrows) on days 1 and 2 with more areas of
atelectasis as well as increased alveolar disruption with hyaline membranes (arrowheads),
proteinaceous debris and haemorrhage. With increasing time there is a reduction in
cellularity as well as a shift from a neutrophilic to a predominantly mononuclear infiltrate.
Scale bars=50μm. g) Lung injury scoring shows a significant injury on days 1 and 2 with a
reduction from day 3 onwards (N=3-4/each time point). Lung injury was assessed on a scale
of 0–2 for each of the following criteria: i) neutrophils in the alveolar space, ii) neutrophils
in the interstitial space, iii) number of hyaline membranes, iv) amount of proteinaceous
debris, and v) extent of alveolar septal thickening. The final injury score was derived from
the following calculation: Score = [20*(i) + 14*(ii) + 7*(iii) + 7*(iv) + 2*(v)] / (number of
fields *100). ***P<0.001, *P<0.05 vs Day 0 uninjured controls.
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Figure 5.
Representative Masson’s trichrome stained sections at a–c) x200 (scale bars=50μm) and d–
f) x1000 (scale bars=10μm) original magnification of uninjured (a and d), and injured
animals at days 2 (b and e) and 10 (c and f) after acid aspiration. There are significant
changes, with cellular infiltration focussed in the peribronchiolar regions. Higher
magnification images show increasing thickness of bronchiolar walls as a result of increased
collagen deposition already at day 2 (e), and increasing over the course of the injury. This is
particularly apparent at day 10 (c) which shows multiple fibrotic foci (black arrow). BL:
bronchiolar lumen.
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